Can-Fite BioPharma Ltd. Sponsored ADR
(NYSE Amex Equities : CANF)

( )
CANF PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
AMGNAmgen Inc.
0.00%183.551.1%$846.87m
GILDGilead Sciences, Inc.
0.00%80.700.9%$816.69m
CELGCelgene Corporation
0.00%95.261.2%$791.42m
JUNOJuno Therapeutics, Inc.
0.00%85.1013.5%$584.15m
BIIBBiogen Inc.
0.00%291.871.2%$500.99m
REGNRegeneron Pharmaceuticals, Inc.
0.00%332.152.7%$399.78m
VRTXVertex Pharmaceuticals Incorporated
0.00%160.721.9%$358.41m
ALXNAlexion Pharmaceuticals, Inc.
0.00%120.472.0%$256.63m
NKTRNektar Therapeutics
0.00%83.436.0%$246.17m
ILMNIllumina, Inc.
0.00%229.203.5%$234.08m
BLUEBluebird Bio, Inc.
0.00%213.3516.1%$201.76m
AAgilent Technologies, Inc.
0.00%71.941.5%$173.78m
INCYIncyte Corporation
0.00%86.032.5%$158.32m
EXASExact Sciences Corporation
0.00%48.8626.0%$132.16m
BMRNBioMarin Pharmaceutical Inc.
0.00%84.984.4%$122.34m

Company Profile

Can-Fite BioPharma Ltd. operates as a clinical-stage biopharmaceutical company, which focuses on developing orally bioavailable small molecule therapeutic products for the treatment of autoimmune-inflammatory, oncological and ophthalmic diseases. Its products include pipeline drugs such as CF101, CF102 and CF602. The company offers drugs for the treatment of Psoriasis, Rheumatic Arthritis, Glaucoma, Uveitis, Crohn's disease, Osteoathritis, Hepatitis C, and Liver Cancer. Can-Fite BioPharma was founded by Pnina Fishman and Ilan Cohn on September 11, 1994 and is headquartered in Petach Tikva, Israel.